News Pharma Industry

AstraZeneca: From AstraZeneca to Pfizer, Big Pharma is banking on India’s data and IT chops for cutting-edge R&D

[ad_1]

Synopsis

In a nod to India’s clinical development and data-analysis skills, top multinational pharma companies are setting up labs and research facilities in the country to support their global programmes. The trend is fast gathering momentum, but how did it come about, and can India keep pace with developments across the globe?

When a deadly virus had the world in its grip two years ago, scientists were faced with an uphill task of finding a vaccine — and fast. A team of gritty virologists at Oxford University and drug maker AstraZeneca took on the task. They could have got waylaid into a maze, or emerge as saviours, but the uncertainties and risks did not hold them back. Before the year was out, it was clear their work would help rein in the rampaging virus.A Lancet

  • FONT SIZE
  • SAVE
  • PRINT
  • COMMENT

Why ?

  • Exclusive Economic Times Stories, Editorials & Expert opinion across 20+ sectors

  • Stock analysis. Market Research. Industry Trends on 4000+ Stocks

  • Clean experience with
    Minimal Ads

  • Comment & Engage with ET Prime community

  • Exclusive invites to Virtual Events with Industry Leaders

  • A trusted team of Journalists & Analysts who can best filter signal from noise

[ad_2]

Source link